Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C518576 |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate results in decreased expression of NOG mRNA | decreases expression | 17327690
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NOG mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NOG mRNA | affects expression | 16483693
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of NOG mRNA | affects cotreatment|decreases expression | 20360939
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of NOG mRNA | affects cotreatment|decreases expression | 20360939
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in decreased expression of TNFSF11 mRNA] | decreases expression|decreases reaction | 19747809
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA] | decreases reaction|increases expression | 18295595
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in increased expression of BMP2 mRNA] | decreases reaction|increases expression | 19747809
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in increased expression of RUNX2 mRNA] | decreases reaction|increases expression | 18295595 19747809
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in increased expression of SMAD4 mRNA] | decreases reaction|increases expression | 19747809
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA] | decreases reaction|increases expression | 18295595
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in increased expression of TNFRSF11B mRNA] | decreases reaction|increases expression | 19747809
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of NOG mRNA | increases expression | 12832660
|
D014212 |
Tretinoin |
[Tretinoin co-treated with EGF protein co-treated with NOG protein] results in increased expression of SOX10 mRNA | affects cotreatment|increases expression | 17196394
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.98 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
11.24 | 18056438 19052882 17620307 16434500 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.24 | 16434500 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.81 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
icariin |
3.80 | 19782061 19858766 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.22 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.40 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.68 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.80 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.80 | 16197459 16206674 |
MESH:D001847 |
Bone Diseases |
|
icariin |
6.74 | 18295595 |
OMIM:611377 |
BRACHYDACTYLY, TYPE B2 |
marker/mechanism |
|
| |
MESH:D002545 |
Brain Ischemia |
|
icariin |
5.81 | 19303870 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.15 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.15 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.93 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.71 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.71 | 19107877 16878318 19394651 17761372 21159647 19171122 18393292 10672840 16807293 20514400 17428255 16698587 19519916 17138121 18691550 16540662 19335982 16935385 16681979 17978847 20101231 19539802 18210153 17055752 10737359 20727157 18665156 19208518 20007298 18506893 19052882 16328049 3084413 16569478 19701751 16830150 3581430 20214788 19822196 16502159 20935162 19919837 20432363 18788625 19418558 16288022 11831363 17173139 18494052 18978308 20512989 20084675 18056438 16779866 17162532 18785209 18971187 20524982 19383236 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.71 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.34 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.66 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.66 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.01 | 17174075 7505956 2727394 21159647 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.93 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.90 | 19052882 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.00 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.75 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.01 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 17551590 9664655 10589399 9211117 16925845 9125849 8800419 9224671 14991402 9142499 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.23 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.94 | 19370779 14550746 2444490 18713872 16081117 11743745 16485898 11739529 16227642 12392966 17522070 12594235 19923254 11529661 19739265 10663392 14986274 19164858 16781746 15619225 11287661 10774834 16109766 12540782 11421492 12153990 17562736 17906064 11834606 19420014 14725611 12958197 19416960 10915739 16393943 18071297 16177239 15968718 11461765 12705907 19085960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.94 | 19107877 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.47 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.72 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.84 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.25 | 16569247 |
MESH:D007172 |
Erectile Dysfunction |
|
icariin |
5.71 | 15329286 16281085 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.49 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.75 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.50 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.50 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.82 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.05 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.15 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.34 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.01 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.30 | 19176532 19772884 16221962 18467677 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
8.27 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.27 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.88 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.48 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.07 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.81 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.14 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.66 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
6.66 | 15369732 |
MESH:D007859 |
Learning Disorders |
|
icariin |
5.62 | 19782061 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.87 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.94 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
8.42 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.42 | 15748426 16788101 12679006 19642359 16935935 17217047 16766008 17294898 16140955 17649720 19029980 19035177 17301526 17712046 17506722 16823087 19225113 19075265 16331271 17107899 16891316 17361223 17368321 17339181 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.47 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.94 | 18522880 19638242 20032147 18407596 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.40 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.40 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.08 | 16611625 12587719 19014921 16610002 19460945 11587558 12969438 19784758 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.08 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.46 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
4.70 | 20137499 19833225 12771043 9163691 20583210 19850985 20101389 19256749 19255062 21071580 19690152 15885732 21278145 20118626 12112319 19426721 18648771 20405173 18977376 10737359 19996281 19551842 19254457 21167192 19499222 20492335 19638242 19073162 19294768 21047994 15175105 18978307 20452335 20501860 19812893 19427195 2422723 18644402 2862719 19090486 16942905 18754104 20434301 19642983 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.70 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.77 | 18544905 9362446 18775883 19004024 19519916 17942915 18282651 18253720 18079962 21159647 19009564 18308698 16267830 17854601 19539802 17174075 19126423 16842330 18093689 2563599 3124819 18164116 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 21163286 20970405 6695378 20512841 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.86 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.87 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
icariin |
5.58 | 19782061 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.73 | 16940565 |
MESH:C537379 |
Multiple synostoses syndrome 1 |
marker/mechanism |
|
| |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.20 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.65 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.26 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.26 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.06 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.20 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.86 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.86 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.49 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
icariin |
4.75 | 19747809 18236786 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.40 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.26 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.26 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.49 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.49 | 15976015 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.77 | 2563599 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.86 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.13 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.36 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.70 | 16467112 |
OMIM:184460 |
STAPES ANKYLOSIS WITH BROAD THUMB AND TOES |
marker/mechanism |
|
| |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.47 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.47 | 17261132 |
OMIM:185800 |
SYMPHALANGISM, PROXIMAL |
marker/mechanism |
|
| |
OMIM:186570 |
TARSAL-CARPAL COALITION SYNDROME |
marker/mechanism |
|
| |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.78 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.78 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.02 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.36 | 16040207 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.24 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.90 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.99 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.34 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.18 | 16287080 |